Evidera

Bethesda, United States Founded: 2012 • Age: 14 yrs Acquired By PPD
Evidence-based solutions are provided for biopharmaceutical real-world effectiveness and safety.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 304 Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Evidera

Evidera is a company based in Bethesda (United States) founded in 2012 was acquired by PPD in September 2016. The company has 304 employees as of December 31, 2021. Evidera has completed 2 acquisitions, including GenerasiTogel and Medimix International. Evidera offers products and services including Real-World Evidence Solutions, Patient-Centered Research, and Strategic Development Consulting. Evidera operates in a competitive market with competitors including SSI Strategy, Health Decisions, Fusion Antibodies, Antios Therapeutics and Everest Clinical Research, among others.

  • Headquarter Bethesda, United States
  • Employees 304 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Evidera, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    STG

    & 1 more

  • Employee Count
    304

    as on Dec 31, 2021

  • Investments & Acquisitions
  • Acquired by
    PPD

    & 1 more

    (Sep 06, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Evidera

Evidera offers a comprehensive portfolio of products and services, including Real-World Evidence Solutions, Patient-Centered Research, and Strategic Development Consulting.

Product name locked
Category locked
Primary

Generates insights from real-world data for drug development and approval.

Product name locked
Category locked
Locked

Reduces patient burden in clinical trials for better recruitment.

Product name locked
Category locked
Locked

Provides tailored strategies for regulatory and clinical needs.

People of Evidera

Headcount 500-1000
Employee Profiles 199
Employee Profiles
People
Withney Altema
Research Associate I
People
Aiswarya Shree
Research Associate 1
People
Angelica Jiongco
Research Associate II
People
Ashley Samuelson Mph, Rdn
Research Associate I

Unlock access to complete

Funding Insights of Evidera

Premium access

Detailed funding history for Evidera

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Evidera

Evidera has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include STG and PPD.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
A private equity firm focused on mid-market software leaders.
Locked Locked Locked
CRO providing diversified clinical development services
Locked Locked Locked
Premium access

Investor details for Evidera

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Evidera

Evidera has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include GenerasiTogel and Medimix International.

Investments
Premium access

Investment portfolio details for Evidera

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Human physiology, diseases, and healthcare systems are modeled for simulations.
Locked Locked 2006 Locked
Business intelligence software is provided to pharmaceutical and diagnostics sectors.
Locked Locked 1990 Locked
Premium access

Complete acquisition details for Evidera

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Evidera

Premium access

Detailed financials for Evidera

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Evidera Comparisons

Evidera Primary company
Description
Evidence-based solutions are provided for biopharmaceutical ...
Location
Bethesda, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
304
As of 2021
Premium access

Peer comparison for Evidera

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Evidera

Evidera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Health Decisions, Fusion Antibodies, Antios Therapeutics and Everest Clinical Research, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmacovigilance and medical affairs services are offered for drug development.
Locked Locked Locked
CRO focused on clinical trial services for data management, monitoring and biostatistics
Locked Locked Locked
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
Locked Locked Locked
Innovative therapies for treating and curing viral diseases are developed.
Locked Locked Locked
Full-service clinical research services are provided to life science industries.
Locked Locked Locked
Regulatory and pharmacovigilance support is provided for product lifecycles.
Premium access

Detailed competitors of Evidera

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Evidera

Premium access

Complete news archive for Evidera

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Evidera

Evidera was founded in 2012.

Evidera is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.

As of Dec 31, 2021, the latest employee count at Evidera is 304.

Evidera, acquired by PPD in 2016 is a provider of evidence-based solutions to demonstrate real-world effectiveness and safety of biopharmaceutical products right from early development stages to right until loss of exclusivity. The companys core expertise lies in areas such as health economics, outcomes research, market access, epidemiology, and data analytics. The company offers its services for interventional studies, patient-centred research, pragmaticadaptive studies, modelling and meta-research, market access and medical writing. The companys proprietary software Evalytica, is a software for developing real-world evidence.

Evidera's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.

Evidera offers Real-World Evidence Solutions, Patient-Centered Research, and Strategic Development Consulting.

Evidera has made 2 acquisitions, including GenerasiTogel, and Medimix International.

Evidera has 2 investors. Key investors include STG, and PPD.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available